Fulgent Genetics Inc (FLGT) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Fulgent Genetics Inc   (NASDAQ: FLGT)
    Sector • Healthcare    Industry • Medical Laboratories
   Industry • Medical Laboratories
   Sector • Healthcare


Fulgent Genetics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Fulgent Genetics Inc's ROI in the second quarter of 2026?
Fulgent Genetics Inc recorded a cumulative net loss of $-85 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -7.88%.

Within the Healthcare sector 243 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Jun 30 2026 quarter, so far to 2976, from total ROI ranking in the first quarter of 2026 at 3385.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM -4.82 % -3.12 % -1.81 % -1.74 % -4.3 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 1,017 1,061 1,123 1,137 1,124
Return On Investment (TTM) -7.88 % -6.75 % -5.45 % -3.89 % -4.57 %
FLGT's Overall Ranking # 2976 # 3385 # 2894 # 2929 # 2899
Seq. Investment Change TTM -2.39 % -1.66 % -0.43 % -0.42 % -0.64 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -85 -75 -62 -44 -52

FLGT Company Profile >> Back to FLGT Roi Comparisons >> See Annual FLGT Return On Investment



Return On Investment FLGT's Ranking
Within: No.
Industry # 11
Sector # 244
Overall # 2976

Return On Investment Statistics
High Average Low
100.97 %
8.29 %
-26.7 %
(Mar 31 2021)   (Dec 31 2016)







Financial Statements
Fulgent Genetics Inc's II. Quarter Investments $ 1,017 Millions FLGT's Balance sheet
Fulgent Genetics Inc's II. Quarter Income $ -30 Millions Quarterly FLGT's Income Statement
FLGT's Income by Division See FLGT's Income by Division


FLGT Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 1,123 1,143 1,159 1,301 1,181
Y / Y Investment Growth -1.72 % -1.42 % -10.89 % 10.22 % 106.99 %
Net Income in Millions -62 -44 -175 142 506
Y / Y Net Income Growth - - - -71.97 % 136.22 %
Annual Return On Investment -5.49 % -3.83 % -15.11 % 10.91 % 42.88 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Medical Laboratories Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
FLGT's Roi Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for FLGT's Competitors
Subscribers only: Roi for Fulgent Genetics Inc's Suppliers
Subscribers only: Return On Investment for FLGT's Customers

Other Ratios
FLGT's Roa FLGT's Inventory Turnover Ratio FLGT's Growth Rates FLGT's Dividend Statistics
FLGT's Profitability Ratios FLGT's Asset Turnover Ratio FLGT's Dividend Growth
FLGT's Roe FLGT's Valuation Ratios FLGT's Financial Strength Ratios FLGT's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI

Date modified: 2026-09-14T03:53:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.